Insider Trading activities of Zynerba Pharmaceuticals, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Zynerba Pharmaceuticals, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Zynerba Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Zynerba Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is ZYNE. The reporting company's CIK number is 1621443.
The total value of stock buying since 2005 is $687,409.
The total value of stock sales since 2005 is $31,589.
The total value of stock option exercises since 2005 is $63,508.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Zynerba Pharmaceuticals, Inc. (ZYNE).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-05 10,200 $201,579 0 $0 0 $0
2016-12 17,000 $257,070 0 $0 0 $0
2016-08 0 $0 3,000 $31,589 0 $0
2015-09 0 $0 0 $0 15,957 $63,508
2015-08 15,500 $228,760 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Zynerba Pharmaceuticals, Inc. insiders (ZYNE)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-05-15 Anido Armando (Chairman & Chief Exec. Officer) Buy 1,500 19.57 29,355
2017-05-12 Fickenscher James E (Chief Financial Officer) Buy 5,200 19.82 103,064
2017-05-12 Anido Armando (Chairman & Chief Exec. Officer) Buy 3,500 19.76 69,160
2016-12-29 Rapp Michael Buy 10,000 15.85 158,500
2016-12-07 Fickenscher James E (Chief Financial Officer) Buy 4,000 14.03 56,120
2016-12-06 Fickenscher James E (Chief Financial Officer) Buy 3,000 14.15 42,450
2016-08-16 Hanlon Suzanne M. (Sec, General Counsel & VP HR) Sale 3,000 10.53 31,589
2015-09-11 Baron Richard A (Chief Financial Officer) Option Ex 15,957 3.98 63,508
2015-08-10 Harrison Thomas L (Director) Buy 12,500 14.00 175,000
2015-08-05 Hanlon Suzanne M. (Sec, General Counsel & VP HR) Buy 3,000 17.92 53,760

Insider trading activities including stock purchases, stock sales, and option exercises of ZYNE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Zynerba Pharmaceuticals, Inc. (symbol ZYNE, CIK number 1621443) see the Securities and Exchange Commission (SEC) website.